Results 51 to 60 of about 12,072 (259)

Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention [PDF]

open access: bronzeNew England Journal of Medicine, 2019
Mass administration of azithromycin for trachoma control led to a sustained reduction in all-cause mortality among Ethiopian children. Whether the addition of azithromycin to the monthly sulfadoxine-pyrimethamine plus amodiaquine used for seasonal malaria chemoprevention could reduce mortality and morbidity among African children was unclear.We ...
Daniel Chandramohan   +18 more
openalex   +5 more sources

A proposed method of grading malaria chemoprevention efficacy [PDF]

open access: yes, 2023
The efficacy and effectiveness of antimalarial drugs are threatened by increasing levels of resistance and therefore require continuous monitoring. Chemoprevention is increasingly deployed as a malaria control measure, but there are no generally accepted
Bonnington, C, Nosten, Fh, White, NJ
core   +2 more sources

Seasonal malaria chemoprevention in Africa and China's upgraded role as a contributor: a scoping review. [PDF]

open access: yesInfect Dis Poverty, 2023
Abstract Background Children under five are the vulnerable population most at risk of being infected with Plasmodium parasites, especially in the Sahel region. Seasonal malaria chemoprevention (SMC) recommended by World Health Organization (WHO), has proven to be a highly effective intervention to prevent malaria.
Xu M   +10 more
europepmc   +4 more sources

Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial

open access: goldPLOS ONE, 2018
Seasonal malaria chemoprevention (SMC), the administration of complete therapeutic courses of antimalarials to children aged 3-59 months during the malaria transmission season, is a new strategy recommended by the World Health Organization (WHO) for malaria control in Sahelian countries such as Mali with seasonal transmission.
Amadou Barry   +10 more
openalex   +6 more sources

Modelling the public health impact of second-generation malaria vaccines [PDF]

open access: yes, 2022
Despite significant progress in the control and elimination of malaria over the past two decades, the global burden remains high. The COVID-19 pandemic has seen malaria cases and deaths increase markedly over 2019 resulting in 241 million malaria cases ...
Thompson, Hayley Adelaide
core   +1 more source

Spontaneous adverse drug reaction reporting during the seasonal malaria chemoprevention campaign in 2022

open access: yesBulletin of the National Research Centre, 2023
Background Seasonal administration of antimalaria drug, sulphadoxine/pyrimethamine plus amodiaquine to children 3–59 months is a malaria preventive intervention used for the reduction of childhood malaria morbidity and mortality in area with highly ...
Kunle Rotimi   +11 more
doaj   +1 more source

Malaria chemoprevention and drug resistance: a review of the literature and policy implications

open access: yesMalaria Journal, 2022
Chemoprevention strategies reduce malaria disease and death, but the efficacy of anti-malarial drugs used for chemoprevention is perennially threatened by drug resistance.
Christopher V. Plowe
doaj   +1 more source

Home - About - Disclaimer - Privacy